Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – Still a Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares gapped up before the market opened on Wednesday. The stock had previously closed at $6.23, but opened at $6.40. Coloplast A/S shares last traded at $6.38, with a volume of 2,890 shares.

Coloplast A/S Stock Up 0.8%

The firm has a market cap of $14.56 billion, a PE ratio of 34.00, a price-to-earnings-growth ratio of 2.28 and a beta of 0.21. The company has a quick ratio of 0.94, a current ratio of 1.56 and a debt-to-equity ratio of 1.51. The business has a 50-day moving average price of $6.72 and a two-hundred day moving average price of $6.45.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.10. The company had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%. On average, equities research analysts expect that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.